RRC ID 49215
Author Mikami Y, Fujii S, Nagata K, Wada H, Hasegawa K, Abe M, Yoshimoto RU, Kawano S, Nakamura S, Kiyoshima T.
Title GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas.
Journal J Cancer Res Clin Oncol
Abstract PURPOSE:Keratin 17 (KRT17) has been suggested as a potential diagnostic marker of squamous cell carcinoma including oral squamous cell carcinoma (OSCC). The current study was conducted to clarify the function of KRT17 and its expression mechanism in OSCC.
METHODS:Immunohistochemical analyses were carried out to examine the expression of KRT17, GLI family zinc finger (GLI)-1, GLI-2, or cleaved caspase-3 in OSCCs. The expression of KRT17, GLI-1, or GLI-2 was investigated among OSCC cell lines, and the effects of loss-of-function of KRT17 or GLI, using siRNA or inhibitor, on the cell growth of the OSCC cell line HSC-2 particularly with respect to apoptosis were examined.
RESULTS:Immunohistochemical analyses of tissue specimens obtained from 78 OSCC patients revealed that KRT17 was not observed in non-tumor regions but was strongly expressed at high frequencies in tumor regions. Knockdown of KRT17 increased the number of cleaved caspase-3-positive cells, leading to the reduction of cell number. Loss-of-function of GLI-1 or GLI-2 also increased the cell numbers of apoptotic cells positive for staining of Annexin-V and propidium iodide (PI) and the terminal deoxynucleotidyl transferase dUTP-biotin nick-end labeling (TUNEL) method, and induced DNA fragmentation. This inhibitory effect on cell growth was partially rescued by exogenous KRT17 expression. In the KRT17-positive regions in OSCCs, GLI-1 or GLI-2 was frequently detected, and the number of cells with cleaved caspase-3 positive was decreased.
CONCLUSIONS:KRT17 promotes tumor cell growth, at least partially, through its anti-apoptotic effect as a result of the KRT17 overexpression by GLIs in OSCC.
Volume 143(8)
Pages 1381-1393
Published 2017-8-1
DOI 10.1007/s00432-017-2398-2
PII 10.1007/s00432-017-2398-2
PMID 28342001
MeSH Apoptosis / genetics Biomarkers, Tumor / genetics* Carcinoma, Squamous Cell / genetics* Carcinoma, Squamous Cell / pathology Cell Line, Tumor Cell Proliferation / genetics Gene Expression Regulation, Neoplastic Humans Keratin-17 / biosynthesis Keratin-17 / genetics* Mouth Mucosa / pathology Mouth Neoplasms / genetics* Mouth Neoplasms / pathology Zinc Finger Protein GLI1 / biosynthesis* Zinc Finger Protein GLI1 / genetics
IF 3.656
Times Cited 13
DNA material pcDNA3.1-His-hGLI1 (RDB08063) pcDNA3.1-His-Gli2 (RDB08065) CSII-CMV-MCS-IRES2-Bsd (RDB04385)